Abstract
Cordyceps, an entomopathogenic mushroom, is a famous traditional Chinese medicinal herb (TCM). This higher fungus contains various known and untapped bioactive metabolites, and is looked at as an important source of natural drugs while simultaneously provides good opportunities for discovering new drugs with immunomodulatory, antitumor, hypoglycemic and hypocholesterolemic functions. Therefore, the Cordyceps spp. has been receiving an increasing interest around the world as an interesting natural drug resource. Various secondary metabolites from Cordyceps fungi were reported to have antitumor activities, and antitumor mechanism of those bioactive compounds possesses multi-target, multi-level and multi-pathway characteristics. Challenges in investigations on Cordyceps fungi include the further elucidation of antitumor molecular mechanism and relationship between structure and function of their secondary metabolites.
Keywords: Cordyceps spp., secondary metabolite, antitumor, bioactivity, acting mechanism, Traditional Chinese Medicine (TCM)
Recent Patents on Biotechnology
Title: Secondary Metabolites from Cordyceps Species and Their Antitumor Activity Studies
Volume: 1 Issue: 2
Author(s): Jian-Hui Xiao and Jian-Jiang Zhong
Affiliation:
Keywords: Cordyceps spp., secondary metabolite, antitumor, bioactivity, acting mechanism, Traditional Chinese Medicine (TCM)
Abstract: Cordyceps, an entomopathogenic mushroom, is a famous traditional Chinese medicinal herb (TCM). This higher fungus contains various known and untapped bioactive metabolites, and is looked at as an important source of natural drugs while simultaneously provides good opportunities for discovering new drugs with immunomodulatory, antitumor, hypoglycemic and hypocholesterolemic functions. Therefore, the Cordyceps spp. has been receiving an increasing interest around the world as an interesting natural drug resource. Various secondary metabolites from Cordyceps fungi were reported to have antitumor activities, and antitumor mechanism of those bioactive compounds possesses multi-target, multi-level and multi-pathway characteristics. Challenges in investigations on Cordyceps fungi include the further elucidation of antitumor molecular mechanism and relationship between structure and function of their secondary metabolites.
Export Options
About this article
Cite this article as:
Xiao Jian-Hui and Zhong Jian-Jiang, Secondary Metabolites from Cordyceps Species and Their Antitumor Activity Studies, Recent Patents on Biotechnology 2007; 1 (2) . https://dx.doi.org/10.2174/187220807780809454
DOI https://dx.doi.org/10.2174/187220807780809454 |
Print ISSN 1872-2083 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4012 |
Call for Papers in Thematic Issues
Advancements in Plant Genetics and Genomics
This thematic issue will highlight cutting-edge innovations and recent patents across the breadth of plant genetics and genomics. Key topics will include advanced breeding techniques, omics-based approaches, gene editing, trait discovery, and translational applications for crop improvement. Renowned researchers from leading institutions worldwide will provide state-of-the-art insights and future perspectives ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Biomedical Applications of Gold Nanoparticles
Current Topics in Medicinal Chemistry Angiotensin Peptides and Lung Cancer
Current Cancer Drug Targets Defining Features and Exploring Chemical Modifications to Manipulate RNAa Activity
Current Pharmaceutical Biotechnology Imaging of HER-2 Overexpression in Tumors for Guiding Therapy
Current Pharmaceutical Design Pharmacokinetics-Pharmacology Disconnection of Herbal Medicines and its Potential Solutions with Cellular Pharmacokinetic-Pharmacodynamic Strategy
Current Drug Metabolism Quantum Dots in the Therapy: Current Trends and Perspectives
Mini-Reviews in Medicinal Chemistry Synthetic Nanocarriers for Intracellular Protein Delivery
Current Drug Metabolism Psychiatric Side Effects of Interferon Treatment
Current Drug Safety Chemoresistance in Non-Small Cell Lung Cancer
Current Medicinal Chemistry - Anti-Cancer Agents The Biological Activity of the Novel Vinca Alkaloids 4-chlorochablastine and 4-chlorochacristine
Current Cancer Drug Targets The Anticancer Activity of the N-Terminal CARD-Like Domain of Arginine Deiminase (ADI) from Pseudomonas aeruginosa
Letters in Drug Design & Discovery Anti-Genes: siRNA, Ribozymes and Antisense
Current Pharmaceutical Biotechnology Observations of the Mechanisms of Electromediated DNA Uptake - From Vesicles to Tissues
Current Gene Therapy Schistosoma mansoni Changes the Activity of Phase II Drug-Metabolizing Enzymes: Role of Praziquantel as Antibilharzial Drug
Drug Metabolism Letters Melanin-Concentrating Hormone Receptor 1 Antagonists: A New Perspective for the Pharmacologic Treatment of Obesity
Current Medicinal Chemistry Therapeutic Nucleic Acids
Recent Patents on Regenerative Medicine Expression and Single Nucleotide Polymorphism of Poly (ADPRibose) Polymerase-1 in Gastrointestinal Tumours: Clinical Involvement
Current Medicinal Chemistry Transcriptional Control of the Oxidative Stress Response and Implications of Using Plant Derived Molecules for Therapeutic Interventions in Cancer
Current Medicinal Chemistry Potential Molecular Targeted Therapeutics: Role of PI3-K/Akt/mTOR Inhibition in Cancer
Anti-Cancer Agents in Medicinal Chemistry Metabolomics: A Revolution for Novel Cancer Marker Identification
Combinatorial Chemistry & High Throughput Screening